Skip to main content

and
  1. Article

    Open Access

    Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

    Low-grade serous ovarian cancer (LGSOC) typically responds poorly to standard platinum-based chemotherapy and new therapeutic approaches are needed. We describe a remarkable response to targeted therapy in a p...

    Heidi J. Gray, Payel Chatterjee, Rachele Rosati in npj Precision Oncology (2023)

  2. No Access

    Article

    Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis

    In addition to genomic alterations, aberrant changes in post-transcriptional regulation can modify gene function and drive cancer development. RNA-binding proteins (RBPs) are a large class of post-transcriptio...

    Ng Desi, Qing Yun Tong, Velda Teh, Jia Jia Chan in Cellular and Molecular Life Sciences (2022)

  3. Article

    Open Access

    Genetic mutations in RNA-binding proteins and their roles in ALS

    Mutations in genes that encode RNA-binding proteins (RBPs) have emerged as critical determinants of neurological diseases, especially motor neuron disorders such as amyotrophic lateral sclerosis (ALS). RBPs a...

    Katannya Kapeli, Fernando J. Martinez, Gene W. Yeo in Human Genetics (2017)

  4. Article

    Open Access

    Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses

    The RNA-binding protein (RBP) TAF15 is implicated in amyotrophic lateral sclerosis (ALS). To compare TAF15 function to that of two ALS-associated RBPs, FUS and TDP-43, we integrate CLIP-seq and RNA Bind-N-Seq ...

    Katannya Kapeli, Gabriel A. Pratt, Anthony Q. Vu, Kasey R. Hutt in Nature Communications (2016)